Skip to main content
The University
of
North Carolina
at
Chapel Hill
Accessibility
UNC Calendar
Libraries
Maps
Departments
ConnectCarolina
Search UNC
Collaborative Studies
Coordinating Center
Services
Study Design
Study Implementation
Data Analysis and Reporting
Projects
Accelerating COVID-19 Therapeutic Interventions and Vaccines, The ACTIV-1 Immune Modulator (IM); Immune Modulators for Treating COVID-19 (ACTIV-1 IM)
Aging and Cognitive Health Evaluation in Elders
Atherosclerosis Risk in Communities
ARIC Neurocognitive Study
Adolescent Medicine Trials Network for HIV/AIDS Interventions
Back Pain Consortium Research Program
Biomarkers for Evaluating Spine Treatment
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease
Hispanic Community Health Study / Study of Latinos
Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE)
Predicting Responses to Standardized Pediatric Colitis Therapy
SPIROMICS Study of Early COPD Progression
Subpopulations and Intermediate Outcome Measures in COPD Study
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction
Trial to Assess Chelation Therapy 2
Women's Health Initiative
Legacy
About
Leadership
Investigators
Hosking Fund
Careers
Our Staff
Recent Seminars
Contact
FRP
Fluvastatin Registration Program
Fluvastatin Registration Program (FRP)
Acronym:
FRP
Clinical Centers:
68
Participants:
2,000
Beginning:
1988
Ending:
1991
Study Design:
7 Randomized, double-masked trials, open-label safety study